
Leftfield Investing
Leftfield Investing has 35 stock analyses indexed on RhinoInvestory, covering 28 companies across Consumer Discretionary, Health Care, Industrials and 1 more. Published Dec 2022 – Aug 2026.
Stock Analyses by Leftfield Investing
Replimune recieves accelerated approval
Replimune Group ($REPL) • Published: 2026-08-07
PDEX hits $67 USD/share
Pro-Dex, Inc. ($PDEX) • Published: 2026-08-04
Clearpoint Neuro 5 years of reflection
ClearPoint Neuro ($CLPT) • Published: 2026-08-04
Vaso sells a subsidiary, shares close 38% higher
Vaso Corporation ($VASO) • Published: 2026-08-04
Zedcor has been integrated into direct to dispatch
Zedcor ($ZDC.V) • Published: 2026-08-03
A busted acquisition has made Galaxy Gaming incredibly cheap
Galaxy Gaming, Inc. ($GLXZ) • Published: 2026-07-29
Ken Dart triggers mandatory bid for Evolution Gaming
Evolution AB ($EVVTY) • Published: 2026-07-28
SINTEFs commercial waste refuge into Flerie AB with BSG005
Flerie ($FLERIE.ST) • Published: 2026-07-19
Monogram highlights from the Goldman Sachs 47th Annual Global Healthcare Conference
Monogram • Published: 2026-07-07
Abivax is a lesson
Abivax • Published: 2026-07-01
Planet Microcap & Zimmer Biomet Q1
Planet Microcap • Published: 2026-05-25
Evolutions €2B buyback program.
Evolutions • Published: 2026-05-24
An aging Huntingtons patient treated with AMT-130 goes off disability
AMT-130 • Published: 2026-05-23
Zedcor's latest quarter
Zedcor ($ZDC.V) • Published: 2026-05-22
Fervo IPO @ $27 USD, indicating an OPEN at $40 USD
Fervo • Published: 2026-05-13









